• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth - Product Image

Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

  • Published: November 2012
  • Region: Asia, China, India
  • 95 Pages
  • GBI Research

GBI Research’s report, “Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth”, provides a detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes therapeutic categories analysis and CMO growth in the region, and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Asia-Pacific API market, covering all of the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Asia-Pacific is the second largest regional market for APIs by revenue in the world. The Asia-Pacific active pharmaceutical ingredients market revenue held a share of around 28.3% of the global API market in 2011, with the global revenue READ MORE >

1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Contract Manufacturing Organizations (CMO)
3.1 Process of CMO Outsourcing
3.2 Asia-Pacific CMO Market Drivers
3.2.1 Availability of Low-cost Skilled Manpower
3.2.2 Key Benefits of Outsourcing
3.3 Asia-Pacific CMO Market Revenues and Forecast to 2017

4 Asia-Pacific Active Pharmaceutical Ingredients Market
4.1 Asia-Pacific API Industry Structure
4.2 Asia-Pacific API Distribution Structure
4.3 Asia-Pacific API Market Overview
4.4 Asia-Pacific APIs Market Segmentation
4.4.1 Synthetic APIs
4.4.2 Biotech APIs
4.5 Asia-Pacific APIs Market Drivers
4.5.1 Growing Pharmaceutical Manufacturing Capabilities of Developing Countries Such as China and India are Attracting APIs Manufacturing from Developed Countries
4.5.2 Domestic Market Growth of Developing Countries in Asia-Pacific is Providing Global Pharmaceutical Industry Growth
4.5.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute Significantly to Asia-Pacific APIs Market Growth
4.5.4 The Improving Regulatory Framework in Markets of China and India is Increasing the Penetration of Branded Drugs
4.5.5 Patent Expiries of Blockbuster Drugs Boosting the Market Revenues in Asia-Pacific
4.6 Asia-Pacific APIs Market Restraints
4.6.1 Increasing Patent Expiries Hamper the Growth of the Branded API Market
4.6.2 Highly Fragmented Market Restricts the Revenue Growth of the Asia-Pacific API Market
4.6.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential
4.6.4 High Currency Fluctuations Hamper the Value Growth of the Pharmaceutical Market in the Asia-Pacific Region
4.7 Asia-Pacific APIs Market Revenue and Forecasts to 2017
4.8 Asia-Pacific Revenue Share Analysis by Product Types
4.9 Asia-Pacific Synthetic APIs Market
4.9.1 Asia-Pacific Synthetic APIs Market Drivers
4.9.2 Asia-Pacific Synthetic APIs Market Restraints
4.9.3 Asia-Pacific Synthetic Market Revenues and Forecast to 2017
4.9.4 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base
4.9.5 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017
4.10 Asia-Pacific Biotech APIs Market
4.10.1 Asia-Pacific Biotech APIs Market Drivers
4.10.2 Asia-Pacific Biotech APIs Market Restraints
4.10.3 Asia-Pacific Biotech Market Revenues and Forecasts to 2017
4.10.4 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base
4.10.5 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017
4.11 Asia-Pacific Patent Expiry of Leading Biologics
4.12 Asia-Pacific APIs Market Share Analysis by Therapeutic Applications

5 Japan Active Pharmaceutical Ingredients Market
5.1 Japan APIs Market Overview
5.2 Japan APIs Market Revenue and Forecasts to 2017
5.3 Japan APIs Market Revenue Share Analysis by Product Type
5.4 Japan APIs Market by Customer Base
5.4.1 Japan Synthetic Market Revenue by Customer Base and Forecasts to 2017
5.4.2 Japan Synthetic Market Revenue Share Analysis by Customer Base
5.4.3 Japan Biotech Market Revenue by Customer Base and Forecasts to 2017
5.4.4 Japan Biotech Market Revenue Share Analysis by Customer Base
5.5 Japan APIs Market Share Analysis by Therapeutic Applications

6 China Active Pharmaceutical Ingredients Market
6.1 China APIs Market Overview
6.2 China API Market Revenues by Product Type and Forecasts to 2017
6.3 China APIs Market Revenue Share Analysis by Product Types
6.4 China APIs Market by Customer Base
6.4.1 China Synthetic Market Revenue by Customer Base and Forecasts to 2017
6.4.2 China Synthetic Market Revenue Share Analysis by Customer Base
6.4.3 China Biotech Market Revenue by Customer Base and Forecast to 2017
6.4.4 China Biotech Market Revenue Share Analysis by Customer Base
6.5 China APIs Market Share Analysis by Therapeutic Applications

7 South Korea Active Pharmaceutical Ingredients Market
7.1 South Korea APIs Market Overview
7.2 South Korea APIs Market Revenue and Forecasts to 2017
7.3 South Korea APIs Market Revenue Share Analysis by Product Type
7.4 South Korea APIs Market by Customer Base
7.4.1 South Korea Synthetic Market Revenue by Customer Base and Forecasts to 2017
7.4.2 South Korea Synthetic Market Revenue Share Analysis by Customer Base
7.4.3 South Korea Biotech Market Revenue by Customer Base and Forecasts to 2017
7.4.4 South Korea Biotech Market Revenue Share Analysis by Customer Base
7.5 South Korea APIs Market Share Analysis by Therapeutic Applications

8 India Active Pharmaceutical Ingredients Market
8.1 India APIs Market Overview
8.2 India APIs Market Revenue and Forecasts to 2017
8.3 India APIs Market Revenue Share Analysis by Product Types
8.4 India APIs Market by Customer Base
8.4.1 India Synthetic Market Revenue by Customer Base and Forecasts to 2017
8.4.2 India Synthetic Market Revenue Share Analysis by Customer Base
8.4.3 India Biotech Market Revenue by Customer Base and Forecasts to 2017
8.4.4 India Biotech Market Revenue Share Analysis by Customer Base
8.5 India APIs Market Revenue Analysis by Therapeutic Applications

9 Appendix
9.1 Abbreviations
9.2 Bibliography
9.3 Market Definitions
9.4 Methodology
9.4.1 Coverage
9.4.2 Secondary Research
9.4.3 Primary Research
9.4.4 Expert Panel Validation
9.5 Contact Us
9.6 Disclaimer

1.1 List of Tables

Table 1: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011
Table 2: CMO Market, Asia-Pacific, Revenues, $m, 2005-2017
Table 3: APIs Market, Asia-Pacific, Market Revenues, $m, 2005-2017
Table 4: APIs Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011
Table 5: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005-2017
Table 6: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
Table 7: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries ($m), 2005, 2011 and 2017
Table 8: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011
Table 9: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005-2017
Table 10: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005-2017
Table 11: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
Table 12: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017
Table 13: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011
Table 14: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005-2017
Table 15: Biotech Market , Asia-Pacific, Key Patent Expiries, 2004-2018
Table 16: APIs Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
Table 17: APIs Market, Japan, Market Revenues by Product Types, $m, 2005-2017
Table 18: APIs Market, Japan, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017
Table 19: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005-2017
Table 20: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005, 2011 and 2017
Table 21: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005-2017
Table 22: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
Table 23: APIs Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2011-2017
Table 24: APIs Market, China, Market Revenues by Product Type, $m, 2005-2017
Table 25: APIs Market, China, Revenue Share Analysis by Product Type, %, 2005, 2011 and 2017
Table 26: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005-2017
Table 27: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017
Table 28: Biotech Market, China, Market Revenues by Customer Base, $m, 2005-2017
Table 29: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
Table 30: APIs Market, China, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
Table 31: APIs Market, South Korea, Market Revenues by Product Types, $m, 2005-2017
Table 32: APIs Market, South Korea, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017
Table 33: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017
Table 34: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
Table 35: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017
Table 36: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
Table 37: APIs Market, South Korea, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017
Table 38: APIs Market, India, Market Revenues by Product Types, $m, 2005-2017
Table 39: APIs Market, India, Revenue Share Analysis by Product Types, %, 2005, 2011 and 2017
Table 40: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005-2017
Table 41: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
Table 42: Biotech Market, India, Market Revenues by Customer Base, $m, 2005-2017
Table 43: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005, 2011 and 2017
Table 44: APIs Market, India, Revenue Share Analysis by Therapeutic Applications, %, 2011 and 2017

1.2 List of Figures

Figure 1: CMO Market, Global, CMO Process Selection and Outsourcing Project Management
Figure 2: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011
Figure 3: CMO Market, Key Benefits of CMO Outsourcing
Figure 4: CMO Market, Asia-Pacific, Revenue Forecasts ($m), 2005-2017
Figure 5: APIs Market, Asia-Pacific, Industry Value Chain
Figure 6: APIs Market, Asia-Pacific, Distribution Structure
Figure 7: APIs Market, Asia-Pacific, Product Types
Figure 8: APIs Market, Asia-Pacific, Market Revenues ($m), 2005-2017
Figure 9: APIs Market, Asia-Pacific, Revenue Share by Product Types (%), 2011
Figure 10: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005-2017
Figure 11: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
Figure 12: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid, 2005-2017
Figure 13: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005, 2011 and 2017
Figure 14: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011
Figure 15: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Types ($m), 2005-2017
Figure 16: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005-2017
Figure 17: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
Figure 18: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid, 2005-2017
Figure 19: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005, 2011 and 2017
Figure 20: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011
Figure 21: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005-2017
Figure 22: APIs Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017
Figure 23: APIs Market, Japan, Market Revenues by Product Types ($m), 2005-2017
Figure 24: APIs Market, Japan, Revenue Share Analysis by Product Types (%), 2005, 2011 and 2017
Figure 25: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005-2017
Figure 26: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005, 2011 and 2017
Figure 27: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005-2017
Figure 28: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
Figure 29: APIs Market, Japan, Revenue Share Analysis by Therapeutic Applications (%), 2011-2017
Figure 30: APIs Market, China, Market Revenues by Product Type ($m), 2005-2017
Figure 31: APIs Market, China, Revenue Share Analysis by Product Type (%), 2005, 2011 and 2017
Figure 32: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005-2017
Figure 33: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017
Figure 34: Biotech Market, China, Market Revenues by Customer Base ($m), 2005-2017
Figure 35: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
Figure 36: APIs Market, China, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017
Figure 37: APIs Market, South Korea, Market Revenues by Product Types ($m), 2005-2017
Figure 38: APIs Market, South Korea, Revenues Share Analysis by Product Types (%), 2005, 2011 and 2017
Figure 39: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017
Figure 40: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
Figure 41: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017
Figure 42: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
Figure 43: APIs Market, South Korea, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017
Figure 44: APIs Market, India, Market Revenues by Product Types ($m), 2005-2017
Figure 45: APIs Market, India, Revenue Share Analysis by Product Types (%), 2005, 2011 and 2017
Figure 46: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005-2017
Figure 47: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
Figure 48: Biotech Market, India, Market Revenues by Customer Base ($m), 2005-2017
Figure 49: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005, 2011 and 2017
Figure 50: APIs Market, India, Revenue Share Analysis by Therapeutic Applications (%), 2011 and 2017

Outsourcing in Asia to Shrink Japan’s Revenue Share

Pharma’s interest in outsourcing, combined with rising industrialization in India and China, will mark a drop in Japan’s share of the continent’s revenue, says a new report from pharmaceutical industry experts GBI Research.

The latest report* predicts Japan’s Active Pharmaceutical Ingredients (API) Asia-Pacific revenue share to drop from a dominant 51% in 2011 to 34% by 2017, while less economically mature markets across the region expand their own.

Japan’s API market revenue grew from $9.9 billion in 2006 to $15.6 billion last year, but GBI Research expects this growth to slow substantially in the future, reaching $17.2 billion in 2017, at a modest Compound Annual Growth Rate (CAGR) of just 1.7% from 2011.

By comparison, China’s API market revenue will increase from the $6.6 billion posted last year to $17 billion by the end of 2017, representing a CAGR of 17.2% during the same time period. Similarly, the API industry in India is expected to expand in value, from $2 billion in 2011 to $5.2 billion in 2017, at a CAGR of 17.4%.

A major contributor to this disparity in growth is the growing popularity of outsourcing pharmaceutical processes to Contract Manufacturing Organizations (CMO) in developing countries where skilled workforces are readily available and labor costs can be as much as 12 times lower.

The CMO market for the Asia-Pacific region is expected to jump in value in the near future. From combined revenues of $6.6 billion last year, GBI Research forecasts the sector to reach $16.5 billion by just 2017 at a healthy CAGR of 16.4%.

* Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth

This report presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in the Asia-Pacific region.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GBI Research’s team of industry experts.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos